DeSci (Decentralized Science) is a movement applying blockchain tools — DAOs, tokens, NFTs, smart contracts — to scientific research, aiming to democratize funding access, accelerate discovery, improve reproducibility, and break traditional publishing gatekeepers.
Problems DeSci Addresses
Traditional scientific research faces structural problems:
- Funding concentration: NIH and major grants fund incremental, low-risk research; early-stage and controversial ideas are defunded
- Publish-or-perish: Researchers optimize for publications over real discoveries
- Paywalled knowledge: Published research is locked behind expensive journals
- Slow reproducibility: Failed replications go unpublished; literature is polluted with non-replicable results
- IP loss: Universities own researcher IP, capturing upside and restricting access
DeSci Solutions
| Problem | DeSci Approach |
|---|---|
| Funding | Community DAOs raise capital and allocate grants via token governance |
| IP | Tokenized IP-NFTs letting researchers retain ownership and benefit directly |
| Publication | On-chain research logging; decentralized peer review |
| Reproducibility | Smart contracts releasing payments only on successful replication |
Key DeSci Projects
VitaDAO
- Funds longevity and lifespan extension research via DAO governance
- VITA token holders vote on research grants
- Acquired IP in aging biology drugs and compounds
- Partnered with major longevity researchers and biotech companies
Molecule
- Platform for creating IP-NFTs — converting drug discovery IP into tradeable tokens
- Researchers mint IP-NFTs representing rights to research; bioDAOs fund them
- Infrastructure layer connecting researchers, patients, and capital
LabDAO
- Decentralized marketplace for wet lab services and scientific compute
- Scientists can request or offer lab-as-a-service globally
AthenaDAO
- Focus: Women’s health and reproductive medicine research
- Funded research in PCOS, endometriosis, and fertility science
IP-NFT Model
IP-NFTs (Intellectual Property NFTs) are core to DeSci:
- Researcher mints IP-NFT representing rights to a drug, molecule, or discovery
- DeSci DAO or investors fund the research by acquiring the IP-NFT
- Researcher retains scientific freedom; funders receive economic upside
- If the research succeeds commercially, NFT holders share revenue
Challenges
- Scientific credibility: Peer review and grant selection quality varies
- Regulatory complexity: Drug research involves FDA, IP law, and clinical trials — not compatible with fully decentralized processes
- Small scale: DeSci funding is still a fraction of traditional biomedical research budgets
Sources
- VitaDAO: vitadao.com
- Molecule: molecule.to
- DeSci wiki: https://desci.world